Holen Sie sich die Stockscreener-App
2.19
1.03%
0.0224
Schlusskurs vom Vortag:
$2.1676
Offen:
$2.1999
24-Stunden-Volumen:
19,440
Relative Volume:
0.02
Marktkapitalisierung:
$5.01M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-0.7964
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
+1.86%
1M Leistung:
-11.08%
6M Leistung:
-46.72%
1J Leistung:
-46.28%
1-Tages-Spanne:
$2.16
$2.2492
1-Wochen-Bereich:
$2.10
$2.2492
52-Wochen-Spanne:
$1.90
$13.93
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Firmenname
Xenetic Biosciences Inc
Sektor
Branche
Telefon
781-778-7720
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Vergleichen Sie XBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.185 | 5.01M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.36 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
811.17 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
407.74 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
811.36 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.32 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-08 | Eingeleitet | Maxim Group | Buy |
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Is Xenetic Biosciences Inc. (3XB0) stock safe for risk averse investorsQuarterly Trade Summary & Expert Approved Momentum Ideas - ulpravda.ru
Will Xenetic Biosciences Inc. stock attract more institutional investorsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - ulpravda.ru
Is Xenetic Biosciences Inc. stock a safe haven assetJuly 2025 Opening Moves & Risk Managed Investment Strategies - ulpravda.ru
XBIO: No quorum was reached, so the meeting was adjourned and will be rescheduled - TradingView — Track All Markets
Trend Recap: Is Xenetic Biosciences Inc 3XB0 stock safe for risk averse investorsQuarterly Portfolio Summary & Weekly High Momentum Picks - moha.gov.vn
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform - Fall River Herald News
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting - South Bend Tribune
Xenetic Biosciences, Inc. (NASDAQ:XBIO) Sees Large Drop in Short Interest - Defense World
Is Xenetic Biosciences Inc. stock affected by interest rate hikesCash Flow Trends & Invest With Confidence - bollywoodhelpline.com
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Xenetic Biosciences, Inc. Share Price TodayLive NASDAQ: XBIO Stock Price Charts, History - Upstox
Financial Review: Xenetic Biosciences (NASDAQ:XBIO) & Talphera (NASDAQ:TLPH) - Defense World
Aug Gainers: Will Xenetic Biosciences Inc stock attract more institutional investorsTrend Reversal & High Accuracy Investment Entry Signals - moha.gov.vn
Why Xenetic Biosciences Inc. (3XB0) stock stays on buy listsProduct Launch & High Accuracy Investment Signals - Улправда
Is Xenetic Biosciences Inc. (3XB0) stock dividend growth reliableQuarterly Earnings Summary & Community Verified Swing Trade Signals - Улправда
Bank Watch: Can Xenetic Biosciences Inc. stock sustain institutional interestJuly 2025 Highlights & Weekly Breakout Stock Alerts - Улправда
Will Xenetic Biosciences Inc. stock outperform growth indexesPortfolio Return Report & Reliable Entry Point Alerts - DonanımHaber
Can Xenetic Biosciences Inc. stock sustain institutional interest2025 Earnings Surprises & Daily Stock Momentum Reports - Улправда
Is Xenetic Biosciences Stock Built to Withstand More Downside? - Trefis
Published on: 2025-12-19 04:46:10 - Улправда
Is Xenetic Biosciences Inc. stock gaining market sharePortfolio Risk Report & Low Risk Entry Point Tips - Улправда
Published on: 2025-12-18 17:05:35 - Улправда
Contrasting Cosmos Health (NASDAQ:COSM) and Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences Earnings Notes - Trefis
Value Recap: Will Xenetic Biosciences Inc stock attract more institutional investorsMarket Performance Report & Verified Technical Signals - moha.gov.vn
Xenetic Biosciences adjourns 2025 annual meeting - MSN
Xenetic Biosciences Adjourns 2025 Annual Meeting - TipRanks
Xenetic Biosciences (NASDAQ: XBIO) Resets 2025 Annual Meeting to Jan. 8, 2026 - Stock Titan
Can Xenetic Biosciences Stock Recover If Markets Fall? - Trefis
EBITDA per share of Xenetic Biosciences, Inc. – BER:3XB0 - TradingView
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock - SouthCoastToday.com
Will Xenetic Biosciences Inc. stock keep outperforming rivals2025 Buyback Activity & Risk Controlled Stock Alerts - Newser
Published on: 2025-12-05 14:51:47 - moha.gov.vn
Is Xenetic Biosciences Inc. (3XB0) stock a top hedge fund pick2025 Top Gainers & Reliable Volume Spike Trade Alerts - Newser
Is Xenetic Biosciences Inc. (3XB0) stock a buy for dividend portfoliosWeekly Stock Report & Real-Time Sentiment Analysis - Newser
Xenetic Biosciences, Inc. (XBIO) Jumps 10% in Pre-market: What’s Driving the Move? - Stocks Telegraph
Can Xenetic Biosciences Inc. (3XB0) stock reach $200 price targetJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):